[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL136828A - CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) - Google Patents

CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)

Info

Publication number
IL136828A
IL136828A IL13682898A IL13682898A IL136828A IL 136828 A IL136828 A IL 136828A IL 13682898 A IL13682898 A IL 13682898A IL 13682898 A IL13682898 A IL 13682898A IL 136828 A IL136828 A IL 136828A
Authority
IL
Israel
Prior art keywords
toluoylpyrrole
methyl
med
polymorphic form
crystalline polymorphic
Prior art date
Application number
IL13682898A
Other languages
English (en)
Other versions
IL136828A0 (en
Original Assignee
Sigma Tau Ind Farmaceuti
Medosan Ind Biochimi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Medosan Ind Biochimi filed Critical Sigma Tau Ind Farmaceuti
Publication of IL136828A0 publication Critical patent/IL136828A0/xx
Publication of IL136828A publication Critical patent/IL136828A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
IL13682898A 1997-12-24 1998-12-16 CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) IL136828A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000811A IT1297140B1 (it) 1997-12-24 1997-12-24 Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e
PCT/IT1998/000363 WO1999033797A1 (en) 1997-12-24 1998-12-16 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)

Publications (2)

Publication Number Publication Date
IL136828A0 IL136828A0 (en) 2001-06-14
IL136828A true IL136828A (en) 2005-08-31

Family

ID=11405418

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13682898A IL136828A (en) 1997-12-24 1998-12-16 CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)

Country Status (22)

Country Link
US (1) US6288241B1 (de)
EP (1) EP1082304B1 (de)
JP (1) JP4693236B2 (de)
KR (1) KR100554704B1 (de)
CN (1) CN1200930C (de)
AT (1) ATE255562T1 (de)
AU (1) AU781283B2 (de)
BR (1) BR9814476A (de)
CA (1) CA2315835C (de)
CZ (1) CZ297132B6 (de)
DE (1) DE69820301T2 (de)
DK (1) DK1082304T3 (de)
ES (1) ES2210853T3 (de)
HK (1) HK1035717A1 (de)
HU (1) HU228112B1 (de)
IL (1) IL136828A (de)
IT (1) IT1297140B1 (de)
PL (1) PL197768B1 (de)
PT (1) PT1082304E (de)
SK (1) SK284777B6 (de)
TR (1) TR200001867T2 (de)
WO (1) WO1999033797A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2020175023A1 (ja) * 2019-02-28 2021-12-16 国立大学法人東京工業大学 アミドの製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1210673B (it) * 1982-02-26 1989-09-20 Medosan Ind Biochimi Antinfiammatoria amidi pirrolacetiche ad attivita'
IT1148117B (it) * 1982-03-05 1986-11-26 Medosan Ind Biochimi Attivita'antiflogistica,analgesica,antipiretica,mucolitica e seda tiva della tosse dell'1 metil-5-p-tolilpirrol-2-acetato di 2'metossi-fenile
IT1197688B (it) * 1983-07-29 1988-12-06 Medosan Ind Biochimi Attivita' antiflogistica,analgesica,antipiretica ed antiaggregante piastrinica di 1-metil-5-metilbenzoilpirrol-2-acetamido acetanilidi
IT1278144B1 (it) * 1995-07-14 1997-11-17 Medosan Ricerca Srl Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo.
DE69721077T2 (de) * 1997-08-08 2004-02-05 Medosan Ricerca S.R.L. Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrrol-2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung

Also Published As

Publication number Publication date
SK284777B6 (sk) 2005-11-03
PL341424A1 (en) 2001-04-09
ES2210853T3 (es) 2004-07-01
AU1782899A (en) 1999-07-19
PL197768B1 (pl) 2008-04-30
CA2315835A1 (en) 1999-07-08
EP1082304A1 (de) 2001-03-14
HK1035717A1 (en) 2001-12-07
CZ297132B6 (cs) 2006-09-13
DK1082304T3 (da) 2004-04-05
KR100554704B1 (ko) 2006-02-24
HUP0101025A1 (hu) 2001-08-28
BR9814476A (pt) 2000-10-10
US6288241B1 (en) 2001-09-11
HUP0101025A3 (en) 2001-09-28
DE69820301T2 (de) 2004-10-14
HU228112B1 (en) 2012-11-28
ITRM970811A1 (it) 1999-06-24
CN1283185A (zh) 2001-02-07
EP1082304B1 (de) 2003-12-03
IL136828A0 (en) 2001-06-14
SK8952000A3 (en) 2000-12-11
DE69820301D1 (de) 2004-01-15
PT1082304E (pt) 2004-04-30
JP4693236B2 (ja) 2011-06-01
WO1999033797A1 (en) 1999-07-08
CA2315835C (en) 2008-03-25
ATE255562T1 (de) 2003-12-15
TR200001867T2 (tr) 2000-12-21
IT1297140B1 (it) 1999-08-03
CZ20002336A3 (cs) 2000-12-13
CN1200930C (zh) 2005-05-11
JP2001527064A (ja) 2001-12-25
KR20010033497A (ko) 2001-04-25
AU781283B2 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
BG108806A (en) IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF
AU7035094A (en) New 11-benzaldoxime-estradiene-derivatives, methods for their production and pharmaceuticals containing these substances
BG103268A (en) Propionic acid derivatives and their application
AU4010395A (en) Compositions for increased bioavailability of orally delivered therapeutic agents
HUP0002037A3 (en) Hydroximic acid derivatives, use of them for producing pharmaceutical compositions suitable for inhibiting matrix metalloproteinas and pharmaceutical compositions containing the compounds
HUP0101791A2 (hu) Gamma-amino-vajsav-származékokat tartalmazó szilárd kompozíciók és eljárás a kompozíciók előállítására
AU7035194A (en) 11-benzaldoxime-17beta-methoxy-17alpha- methoxymethylestradiene-derivatives, methods for their production and pharmaceuticals containing these substances
BR9912010A (pt) Polimorfo de um produto farmacêutico
UA35607C2 (uk) Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання
AU1306795A (en) Anticonvulsant pseudofructopyranose sulfamates
AU3176695A (en) Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid
AU9270498A (en) Tricyclic compounds, preparation method and said method intermediates, appl ication as medicines and pharmaceutical compositions containing same
AU4878997A (en) Novel isoxazol derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the novel compounds
IL136828A0 (en) NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETA MIDOACETIC ACID GUAIACYL ESTER (MED 15)
AU3950095A (en) Compositions and methods for detection of 2,4-dichlorophenoxyacetic acid and related compounds
AU6058496A (en) New aminophenylphosphonic acid compounds, process for preparing them and pharmaceutical compositions containing them
CA2136071A1 (en) 2-arylpropionic acid compositions and process for preparing the same
AU7470098A (en) Antithrombotic agents
ES8702489A1 (es) Procedimiento para preparar un pseudooligosacarido
WO1998014454A3 (en) (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES
ES8302623A1 (es) "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxipropionico".
UA41981C2 (uk) Біотинові сполуки, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
HUP9800623A3 (en) Application of (+)-o-demethyl-tramadol for production of oral analgesic pharmaceutical compositions
IT8421609A0 (it) Estere dell'acido (+)6-metossi-alfa-metil-2-naftalenacetico avente attivita'mucosecretolitica, antinfiammatoria, analgesica, antipiretica, procedimento per lasua preparazione e sue composizioni farmaceutiche.
HUP0000080A3 (en) Phosphonic acid derivatives with metallopeptidase inhibitor activity, process for preparing them and pharmaceutical compositions of the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired